Despite increasing prevalence in critical care units, cardiogenic shock related to HF (HF-CS)
is incompletely understood and distinct from acute myocardial infarction related CS. This …

While chronic heart failure (CHF) treatment has considerably improved patient prognosis
and survival, the therapeutic management of acute heart failure (AHF) has remained virtually …

Cardiogenic shock is a complex and diverse pathological condition characterized by
reduced myocardial contractility. The goal of treatment of cardiogenic shock is to improve …

Shock teams likely improve patient outcomes by facilitating early patient phenotyping and
appropriate intervention. Institutions should strongly consider adopting a multidisciplinary …

Acute heart failure is a heterogeneous clinical syndrome and is the first cause of unplanned
hospitalization in people> 65 years. Patients with heart failure may have different clinical …

Aims This multicentre, randomized, controlled, double‐blind, parallel‐group Phase III study
was conducted to confirm the non‐inferiority of OPC‐61815 (tolvaptan sodium phosphate) …

Background Achieving prompt euvolemic state in heart failure (HF) is associated with
reduced mortality. Time-sensitive metrics such as door-to-diuretic time, or the time between …

Aims We investigated the effects of door‐to‐tolvaptan (D2T) time on short‐term urine volume
and in‐hospital clinical outcomes in patients with acute heart failure (AHF). Methods and …

Heart failure (HF) is a chronic, progressive, and increasingly prevalent syndrome
characterized by stepwise declines in health status and residual lifespan. Despite significant …

Abstract Purpose In Japan, carperitide has been recommended for the treatment of
pulmonary congestion in patients with acute heart failure. Identifying useful indicators to …